Navigation Links
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
Date:5/30/2009

es the dissemination of information about cancer and cancer treatment to patients and their families; and, through its grant program, supports, encourages and recognizes excellence in clinical research in the field of oncology.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost-containment
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
2. Wyeth Reports Earnings Results for the 2009 First Quarter
3. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
4. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
5. Wyeth Reduces Risk with Dyadem Software
6. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
7. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
8. DRI - the Voice of the Defense Bar Responds to Supreme Court Ruling in Wyeth v. Levine
9. Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
10. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
11. Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... its name in July to Kalamazoo Strength & Conditioning. , The name change ... “reflects the evolution of our training center over the past three years,” according ...
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage ... by a group of experienced investors, has tapped into an investor community passionate about ... a part of the fund. The Sofia Fund II is now closed to ...
(Date:7/29/2015)... ... July 29, 2015 , ... July is National UV Awareness Month, and in honor ... shares tips on how to protect skin from the sun, as well as how to ... and is one of the most common skin conditions in America. Many people do not ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... in a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in ... catheter options, offers a less invasive, patient-friendly alternative to traditional chest ports and ...
(Date:7/29/2015)... Canada (PRWEB) , ... July 29, 2015 , ... ... as a “forward thinker.” Since the late 1970s, Dr. Cottrell has been making ... new book, The New Earth, documents many of these prognostications. He warns that ...
Breaking Medicine News(10 mins):Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
... multi-million dollar gift from one of Rochester,s hometown ... Rochester Medical Center,s (URMC) neuromedicine program into ... treating neurological conditions such as Alzheimer,s disease, Parkinson,s ... brain and spinal cord. ...
... Company, Inc. (Nasdaq: IPCM ), a leading national ... M.D., Chairman and CEO of IPC The Hospitalist Company, was ... Modern Physician as one of the 50 most powerful ... publications on Monday, May 11th.Jeffrey Taylor, IPC,s President and COO, ...
... SEATTLE, May 13 On Sunday, May 17, traffic near ... Seattle will be temporarily suspended for the 27th annual Nordstrom ... the Juvenile Diabetes Research Foundation. Montlake Closures ... be closed from NE Pacific Street to 44th Avenue NE. ...
... the Office on Women,s HealthWASHINGTON, May 13 The Southern ... web project that collects and shares video stories of women ... announced that it has posted its 100th patch, featuring Frances ... the U.S. Department of Health and Human Services. The milestone ...
... First and only oral antidiabetic fixed-dose combination medication ... and OSAKA, Japan, May 13 Takeda Pharmaceutical ... North America, Inc., today announced that ... an extended-release version of the combination medication ACTO ...
... Technology (CCHIT®) today announced that Glenwood System LLC’s ( http://www.GlenwoodSystems.com ... EHR, and meets the Certification Commission’s electronic health record (EHR) ... offices and clinics where most Americans get their healthcare. ... ...
Cached Medicine News:Health News:$10 Million Gift to Transform Neuromedicine at URMC 2Health News:$10 Million Gift to Transform Neuromedicine at URMC 3Health News:$10 Million Gift to Transform Neuromedicine at URMC 4Health News:$10 Million Gift to Transform Neuromedicine at URMC 5Health News:IPC The Hospitalist Company CEO Adam Singer Named One of 50 Most Powerful Physician Executives 2Health News:Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17 2Health News:Southern AIDS Living Quilt Posts 100th Video Patch During National Women's Health Week 2Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 2Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 3Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 4Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 2Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 3Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 4
(Date:7/29/2015)...   Decision Resources Group finds that the ... will continue to be hindered in the near ... a longer timeline, however, the outlook is improved. Expanding ... increase the prevalence of osteoarthritic damage and sports-related injuries ... tissue solutions. Coupled with continuing economic recovery across ...
(Date:7/29/2015)... India , July 29, 2015 TAKE Solutions ... foray into the big data market for the Life Sciences ... US-based subsidiary, with an initial investment of 3 million ... healthcare and life sciences market (according to projections by McKinsey) ... and advanced analytics. ...
(Date:7/29/2015)... AIRMONT, N.Y. , July 29, 2015 Touro ... County -based CanniCare,s application for one of five media ... York State Dept. of Health (DOH).  ... with research into medicinal cannabis.  "Our college ... H. Kadish , president of the Touro College System. "There ...
Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 2TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 3Touro College Announces Support for CanniCare's Medical Cannabis License Application 2
... CVS Caremark was selected as one of 20 finalists ... Health Care Consumer Empowerment and Protection. URAC, the nation,s ... 12th Annual Quality Summit, October 4-6, 2011 in Chicago, ... Pharmacy Advisor program was selected by a distinguished panel ...
... May 12, 2011 Oncimmune ® LLC , maker ... physicians in the risk assessment and early detection of ... the American Thoracic Society,s (ATS) International Conference May 13 - ... benefits of EarlyCDT-Lung .  Oncimmune,s EarlyCDT-Lung test ...
Cached Medicine Technology:CVS Caremark Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 2CVS Caremark Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 3Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 2Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 3Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 4Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 5
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 550 to 700....
Designed to remove cell debris or tissue remnants from the retina....
... Medtronic presents the Streamline family of ... have taken the gold standard in temporary ... that make them easy to use and ... Model 6491 Unipolar Pediatric Temporary Pacing Lead ...
Lytec Medical 2004 practice management software is designed to help you more effectively manage your accounts receivable as well as track authorizations and inventory. Lytec Medical XE provides outst...
Medicine Products: